Published in FASEB J on May 01, 2001
Oxidative stress in the placenta. Histochem Cell Biol (2004) 2.16
Recent insights into the pathophysiology of preeclampsia. Expert Rev Obstet Gynecol (2010) 1.14
Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol (2013) 0.98
The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci (2015) 0.96
Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One (2010) 0.96
Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases. Front Pharmacol (2012) 0.94
Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes. Fertil Steril (2007) 0.92
The placental pursuit for an adequate oxidant balance between the mother and the fetus. Front Pharmacol (2014) 0.90
Protective role of heme oxygenase-1 in Listeria monocytogenes-induced abortion. PLoS One (2011) 0.90
Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm? Br J Pharmacol (2015) 0.89
Heme oxygenase inhibition increases blood pressure in pregnant rats. Am J Hypertens (2013) 0.87
Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation. J Clin Invest (2015) 0.86
Exploring the potential of low doses carbon monoxide as therapy in pregnancy complications. Med Gas Res (2012) 0.83
A role for Nrf2 in redox signalling of the invasive extravillous trophoblast in severe early onset IUGR associated with preeclampsia. PLoS One (2012) 0.80
Nitric oxide and carbon monoxide production and metabolism in preeclampsia. Reprod Sci (2012) 0.79
Heme oxygenase-1 is critically involved in placentation, spiral artery remodeling, and blood pressure regulation during murine pregnancy. Front Pharmacol (2015) 0.79
Heme oxygenase in pregnancy and preeclampsia. Curr Opin Nephrol Hypertens (2013) 0.78
Heme oxygenase-1 promotes migration and β-epithelial Na+ channel expression in cytotrophoblasts and ischemic placentas. Am J Physiol Regul Integr Comp Physiol (2014) 0.77
The heme oxygenases: important regulators of pregnancy and preeclampsia. Am J Physiol Regul Integr Comp Physiol (2014) 0.75
Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines. Clin J Am Soc Nephrol (2016) 0.75
Analysis of heme oxygenase isomers in rat. World J Gastroenterol (2002) 0.75
Increased expression and activity of heme oxygenase-2 in pregnant rat aorta is not involved in attenuated vasopressin-induced contraction. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.75
Resolution of inflammation pathways in preeclampsia-a narrative review. Immunol Res (2017) 0.75
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet (1997) 4.92
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44
Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet (1999) 3.93
Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med (1998) 3.54
Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 2.79
The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet (2000) 2.59
Barriers to xenotransplantation. Nat Med (1995) 2.44
New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. Curr Drug Targets (2000) 2.09
Malaria in pregnancy: adverse effects on haemoglobin levels and birthweight in primigravidae and multigravidae. Trop Med Int Health (2001) 2.05
Fetal effects of combined spinal-epidural vs epidural labour analgesia: a prospective, randomised double-blind study. Anaesthesia (2014) 1.99
Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis. BJOG (2014) 1.91
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation (2000) 1.88
Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal (2005) 1.81
Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant (2010) 1.74
Adaptation of the maternal heart in pregnancy. Br Heart J (1992) 1.70
P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem (2001) 1.63
Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant (2010) 1.55
Macrophage populations in the human placenta and amniochorion. Clin Exp Immunol (1984) 1.51
Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia. Br J Obstet Gynaecol (1994) 1.42
Gestational diseases -- a workshop report. Placenta (2007) 1.41
Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta (2010) 1.40
Comparison of examination of the entire uterine cervix with routine cervical sampling in hysterectomy specimens from women with endometrial cancer. J Clin Pathol (2007) 1.39
Immunohistological characterization of lymphoid cell populations in the early human placental bed. Immunology (1984) 1.38
Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstet Gynecol (2002) 1.37
Bone-marrow origin of endometrial granulocytes in the early human placental bed. J Reprod Immunol (1983) 1.35
Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol (1994) 1.33
Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension (1996) 1.31
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol (2008) 1.30
Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur J Neurosci (2000) 1.29
Prediction of the small for gestational age infant: which ultrasonic measurement is best? Obstet Gynecol (1992) 1.29
Oestrogen and progesterone receptor expression in the female lower urinary tract, with reference to oestrogen status. BJU Int (2000) 1.28
Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. Am J Transplant (2009) 1.27
Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. J Biol Chem (2000) 1.26
MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta (2012) 1.26
CD39 modulates endothelial cell activation and apoptosis. Mol Med (2000) 1.25
Delayed xenograft rejection. Immunol Today (1996) 1.23
Macrophages on intrauterine contraceptive devices produce prostaglandins. Nature (1975) 1.23
Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta (2008) 1.21
Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes. Thromb Haemost (1999) 1.20
Preterm labor: stimulation of arachidonic acid metabolism in human amnion cells by bacterial products. Am J Obstet Gynecol (1987) 1.20
Results of gal-knockout porcine thymokidney xenografts. Am J Transplant (2009) 1.19
Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta (1996) 1.17
Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol (2006) 1.17
Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochem Biophys Res Commun (1998) 1.15
The differential expression of myometrial connexin-43, cyclooxygenase-1 and -2, and Gs alpha proteins in the upper and lower segments of the human uterus during pregnancy and labor. J Clin Endocrinol Metab (1999) 1.15
Relationships between maternal malaria and malarial immune responses in mothers and neonates. Parasite Immunol (1995) 1.13
The T-lymphocyte population in first-trimester human decidua does not express the interleukin-2 receptor. Immunology (1986) 1.12
Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta. Placenta (2004) 1.11
Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab (2000) 1.10
Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry (1999) 1.10
Maternal uniparental disomy for chromosome 2 in association with confined placental mosaicism for trisomy 2 and severe intrauterine growth retardation. Prenat Diagn (1996) 1.10
Reply to: 'the discovery of a new class of synaptic transmitters in smooth muscle fifty years ago and amelioration of coronary artery thrombosis'. Acta Physiol (Oxf) (2013) 1.09
Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab (2003) 1.09
Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation (1998) 1.09
Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase. J Biol Chem (2000) 1.08
Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant (2008) 1.08
Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer. Oncogene (2001) 1.07
Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol (2001) 1.07
Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism (1998) 1.07
Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation (1997) 1.07
Placental amino acid transport and placental leptin resistance in pregnancies complicated by maternal obesity. Placenta (2010) 1.07
Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J (2000) 1.06
Endometrial granulocytes in human decidua react with a natural-killer (NK) cell marker, NKH1. Immunology (1987) 1.06
Increased production of tumor necrosis factor-alpha TNF-alpha by IUGR human placentae. Eur J Obstet Gynecol Reprod Biol (2001) 1.06
Isolation and functional studies of granulated lymphocytes in first trimester human decidua. Clin Exp Immunol (1989) 1.06
Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation (1999) 1.06
Expression of AT1R, AT2R and AT4R and their roles in extravillous trophoblast invasion in the human. Placenta (2010) 1.05
Antigen expression by trophoblast populations in the human placenta and their possible immunobiological relevance. Placenta (1985) 1.05
Xenotransplantation. Adv Immunol (2001) 1.05
Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol (2000) 1.05
Endothelial nitric oxide synthase in placental villous tissue from normal, pre-eclamptic and intrauterine growth restricted pregnancies. Hum Reprod (1997) 1.04
Noise exposure induces up-regulation of ecto-nucleoside triphosphate diphosphohydrolases 1 and 2 in rat cochlea. Neuroscience (2004) 1.04
Xenogeneic endothelial cells activate human prothrombin. Transplantation (1997) 1.03
Immunohistochemical localization of endothelial nitric oxide synthase in human villous and extravillous trophoblast populations and expression during syncytiotrophoblast formation in vitro. Placenta (1995) 1.03
Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation (2000) 1.03
The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function. J Clin Endocrinol Metab (2004) 1.03
Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol (1999) 1.02
Protein nitration in placenta - functional significance. Placenta (2008) 1.02
A novel mammalian wnt gene, WNT8B, shows brain-restricted expression in early development, with sharply delimited expression boundaries in the developing forebrain. Hum Mol Genet (1998) 1.01
A novel oestrogen-binding species in rat granulosa cells. J Endocrinol (1984) 1.01
Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience (2006) 1.00
Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care (1998) 1.00
Uterine gland epithelium in human pregnancy often lacks detectable maternal MHC antigens but does express fetal trophoblast antigens. J Immunol (1984) 1.00
Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cells. Infect Immun (2008) 1.00
Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation (2001) 1.00
Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev (1994) 1.00
Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta (2005) 1.00
Does antenatal pelvic dilation predict renal scarring? Arch Dis Child Fetal Neonatal Ed (2005) 0.99
A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction. Ann Surg (1994) 0.98
Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF. J Immunol (1997) 0.98
Modification of vascular responses in xenotransplantation: inflammation and apoptosis. Nat Med (1997) 0.98